About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Our Expert Views content provides the ideal narrative for businesses, subject matter experts, and those interested in the expert network industry's latest trends and talking points. These in-depth perspectives cover various industries, business verticals, sectors, and regions, supporting our global clientele.
Founder & Director (Apr 2025 – Present)
Industry expert shares insights on nutrition market growth, innovation strategies, technology trends, and investment essentials—highlighting evidence-based products, AI adoption, and the rise of science-backed startups.
Regional GCC Head (Oct 2024 to Present)
This article analyses GCC pharmaceutical market trends, highlighting specialty drugs, biosimilars, and market access challenges while emphasizing innovation, investment priorities, and evolving strategies for sustainable healthcare growth.
Healthcare & Pharma Consultant (Apr 2023 - Present)
Digital health platforms, AI analytics, and real-world data are reshaping GCC pharmaceutical market access, driving growth in biosimilars and digital therapeutics while enhancing patient-centricity, customer engagement, forecasting, and lifecycle management.
Global Market Director & Global Product Manager (Oct 2011 – Present); Denmark
The precision fermentation market, including plant-based foods, is rapidly growing with a 40-46% CAGR, driven by consumer health awareness, ethical production, sustainability goals, and technological innovation globally.
Senior Lead of Physical Therapy (Jul 2025 – Present)
Dry needling is increasingly integrated into clinical workflows with rising use among elite athletes, becoming a standard in high-performance rehab. Demand grows in GCC and Asia, driven by sports injury rehabilitation and government investments in sports medicine.
Co-Founder
The global AI-driven drug discovery market, valued at $1.7–6.3B in 2024, is projected to grow to $8.5–16.5B by 2030–2034, led by oncology. AI reduces R&D costs by up to 70%, accelerates timelines by 1–2 years, and improves success rates. Breakthroughs include generative AI, foundation models, and au